Related Experiment Video
Updated: Jun 1, 2026
10:24
Genetic Incorporation of Biosynthesized L-dihydroxyphenylalanine (DOPA) and Its Application to Protein Conjugation
Published on: August 24, 2018
D-galactose as a vector for prodrug design.
Daniela Melisi1, Annalisa Curcio, Elvira Luongo
1Pharmaceutical and Toxicological Chemistry Department, School of Pharmacy, University Federico II, via Domenico Montesano 49, 80131, Naples, Italy. dmelisi@hotmail.it
Current Topics in Medicinal Chemistry
|June 16, 2011
Summary
D-galactose enhances drug delivery by creating galactosyl prodrugs. These prodrugs improve drug targeting, reduce side effects, and boost pharmacokinetic profiles for better therapeutic outcomes.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Delivery
Background:
- D-galactose is a natural monosaccharide with potential in pharmaceutical applications.
- Traditional drugs often face challenges like poor site specificity, toxicity, and chemical instability.
- Prodrug strategies offer a way to overcome these limitations in drug development.
Purpose of the Study:
- To review the potential of D-galactose as a versatile vector in prodrug design.
- To explore synthetic strategies for creating D-galactose-based prodrugs.
- To highlight the benefits of galactosyl prodrugs in improving drug efficacy and safety.
Main Methods:
- Review of existing literature on D-galactose prodrugs.
- Analysis of different linkage types between D-galactose and parent drugs.
- Examination of studies demonstrating targeted delivery and improved pharmacokinetics.
Main Results:
- Galactosyl prodrugs enhance site specificity, reducing adverse effects.
- Drug-linker chemistry influences targeting capabilities (e.g., brain, liver, cancer cells).
- Improved cellular permeability and pharmacokinetic profiles are achievable with D-galactose conjugation.
Conclusions:
- D-galactose is a valuable tool for designing advanced prodrugs.
- Tailoring linkage strategies allows for precise pharmacological targeting.
- Galactosyl prodrugs represent a promising approach to enhance therapeutic effectiveness and patient safety.
